Arbutus Biopharma Corp. | Ownership
Companies that own Arbutus Biopharma Corp.
RTW Investments LP
5,165,499
9.32%
13,884
2.7%
06/30/2018
PRIMECAP Management Co.
4,000,400
7.22%
0
0.03%
06/30/2018
BlackRock Fund Advisors
2,208,774
3.99%
1,520,489
0%
06/30/2018
SSN Advisory, Inc.
1,764,815
3.19%
0
7.89%
06/30/2018
BMO Asset Management, Inc.
944,513
1.71%
62,090
0.01%
06/30/2018
Morgan Stanley & Co. LLC
733,329
1.32%
221,906
0.01%
06/30/2018
SSgA Funds Management, Inc.
499,079
0.9%
485,319
0%
06/30/2018
D. E. Shaw & Co. LP
470,508
0.85%
-239,954
0.01%
06/30/2018
Goldman Sachs & Co. LLC (Private Banking)
353,338
0.64%
246,668
0%
06/30/2018
Northern Trust Investments, Inc.
296,416
0.54%
296,416
0%
06/30/2018
| Address |
8900 Glenlyon Parkway
Burnaby British Columbia V5J 5J8
Canada
|
|
Employees
|
- |
| Website |
http://www.arbutusbio.com |
| Updated |
07/08/2019 |
| Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada. . |
